Price T Rowe Associates Inc Immatics N.V. Put Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
85Shares Held
68.8MCall Options Held
507KPut Options Held
170K-
Rtw Investments, LP New York, NY10MShares$120 Million1.69% of portfolio
-
Wellington Management Group LLP Boston, MA8.33MShares$100 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$77.4 Million0.86% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.3MShares$75.8 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY4.58MShares$55.1 Million1.01% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $916M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...